Marc Vervloet

COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

Luuk B. Hilbrands, Raphaël Duivenvoorden, Priya Vart et al. · Nephrology Dialysis Transplantation · 2020 · 411 citations · Full text

Medicine, Infectious Diseases, Nephrology +13

Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD study

Johan Sundström, Johan Bodegård, Andreas Bollmann et al. · The Lancet Regional Health - Europe · 2022 · 318 citations · Full text

Medicine, Internal Medicine, Nephrology +17

Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline Update

Markus Ketteler, Geoffrey A. Block, Pieter Evenepoel et al. · Annals of Internal Medicine · 2018 · 317 citations · Full text

Medicine, Chronic Disease Prevention, Nephrology +16

Cross Talk Between the Renin-Angiotensin-Aldosterone System and Vitamin D-FGF-23-klotho in Chronic Kidney Disease

Martin H. de Borst, Marc Vervloet, Piet M. ter Wee et al. · Journal of the American Society of Nephrology · 2011 · 281 citations · Full text

Medicine, Endocrinology, Nephrology +17

Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial

David Z.I. Cherney, Claire C. J. Dekkers, Sean J. Barbour et al. · The Lancet Diabetes & Endocrinology · 2020 · 274 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11